Details

DSEN Abstract: Comparative Efficacy and Safety of Ultra-Long-, Long-, and Intermediate-Acting and Biosimilar Insulins for Type 1 Diabetes: A Systematic Review and Network Meta-Analysis - CIHR

Metadata and links for an archived snapshot.

Source: Canadian Institutes of Health Research
Date: Apr 10, 2025 · edition #2
Timestamp: 2025-04-10T11:06:36.639Z
Language: en
Original URL: https://cihr-irsc.gc.ca/e/54245.html?wbdisable=false
Replay URL: https://replay.healtharchive.ca/job-2/20250410110636/https://cihr-irsc.gc.ca/e/54245.html?wbdisable=false#ha_snapshot=126012
ID: 126012
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

View View diff Raw HTML ↗Metadata JSON ↗Cite Report issue All snapshots

Other snapshots

Apr 10, 2025
legacy-cihr-2025-04
View Details Compare
Apr 10, 2025 · (this snapshot)
legacy-cihr-2025-04
View Details Compare
Apr 10, 2025
legacy-cihr-2025-04
View Details

Archived page preview